Literature DB >> 6199954

Effect of cyclic AMP, db-cyclic AMP and phosphodiesterase inhibitors on histamine inhibition of the contractile response of the mouse vas deferens.

M M Vohra.   

Abstract

Histamine inhibited the contractile response of the mouse vas deferens to various frequencies of stimulation, and the inhibition was inversely related to the frequency of stimulation. This effect of histamine was mimicked by cyclic AMP, db-cyclic AMP and various phosphodiesterase inhibitors (IBMX, aminophylline and theophylline). Histamine-produced inhibition, but not that produced by the other compounds, was blocked by cimetidine. The low concentrations (10-100 microM) of various phosphodiesterase inhibitors caused inhibition but failed to potentiate the inhibitory response to histamine. The basal cyclic AMP levels of the tissues were unaffected at these concentrations of aminophylline. At higher concentrations (1 and 5 mM), however, aminophylline significantly elevated the basal cyclic AMP levels of the tissues and markedly inhibited the contractile response to various frequencies of stimulation but still failed to enhance or potentiate the inhibitory response to histamine. In fact, the inhibitory response to histamine at these concentrations of aminophylline was reduced. Based on these and earlier [3] findings, it is concluded that, although histamine increases the accumulation of cyclic AMP in the mouse vas deferens and although its inhibitory effect on the preparation can be mimicked by both the cyclic nucleotides and phosphodiesterase inhibitors, the involvement of cyclic AMP in the mediation of its inhibitory response is still unresolved.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199954     DOI: 10.1007/bf01966827

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  16 in total

1.  A postsynaptic inhibitory histamine H2-receptor in the mouse isolated vas deferens.

Authors:  M M Vohra
Journal:  Agents Actions       Date:  1979-10

2.  Role of cyclic nucleotides in control of smooth muscle contraction.

Authors:  J Diamond
Journal:  Adv Cyclic Nucleotide Res       Date:  1978

3.  Inhibition and enhancement of the noradrenaline constrictor response by methylxanthines.

Authors:  J H McNeill; J B Hook; R S Davis
Journal:  Can J Physiol Pharmacol       Date:  1973-07       Impact factor: 2.273

4.  The role of cyclic AMP in gastric secretion.

Authors:  R A Levine; D E Wilson
Journal:  Ann N Y Acad Sci       Date:  1971-12-30       Impact factor: 5.691

5.  Accumulation of adenosine 3',5'-monophosphate and relaxation in the rat uterus in vitro.

Authors:  I Polacek; J Bolan; E E Daniel
Journal:  Can J Physiol Pharmacol       Date:  1971-11       Impact factor: 2.273

6.  Lack of interaction between norepinephrine or histamine and theophylline on cardiac cyclic AMP.

Authors:  J H McNeill; F E Coutinho; S C Verma
Journal:  Can J Physiol Pharmacol       Date:  1974-12       Impact factor: 2.273

7.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

8.  Pharmacological characterization of histamine receptors mediating cyclic AMP accumulation in the mouse vas deferens. Sensitivity to H1 and H2 receptor agonists and antagonists.

Authors:  M M Vohra; P K Rautanen
Journal:  Mol Pharmacol       Date:  1982-11       Impact factor: 4.436

9.  Blockade by burimamide of the effects of histamine and histamine analogs on cardiac contractility, phosphorylase activation and cyclic adenosine monophosphate.

Authors:  J H McNeill; S C Verma
Journal:  J Pharmacol Exp Ther       Date:  1974-01       Impact factor: 4.030

10.  Species differences in histamine receptors in the vas deferens.

Authors:  M M Vohra
Journal:  Agents Actions       Date:  1981-05
View more
  2 in total

1.  Importance of frequency and pulse with in field stimulation of the mouse vas deferens: different behaviour of twitch-inhibiting drugs.

Authors:  G Zetler; M Kaschube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

Review 2.  Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action.

Authors:  Ibrahim A Abdel-Hamid
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.